Retasturtide is a recently launched novel GLP-1 receptor agonist demonstrating promising results in the control of type 2 diabetes. This synthetic peptide mimics the actions of naturally produced GLP-1, a hormone that https://hannapewx589655.bcbloggers.com/profile